{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:36:17Z","timestamp":1784082977877,"version":"3.55.0"},"reference-count":17,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Medicine"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>One of the first achievements of molecular biology in lymphoma science was a discovery of cell of origin (COO) classification around 20 years ago with defining activated B-cell like (ABC) and germinal center B-cell like subtypes of diffuse large B-cell lymphoma (DLBCL) with the use of gene expression profiling. These categories were considered important as seemed to present different biology, response to treatment, and prognosis. Immunochemotherapy R-CHOP21 has been a standard of care for 2 decades, and it results in long-term disease-free survival or cure of 60% of patients with DLBCL but efficacy in an individual patient depends on age and other International Prognostic Index clinical risk factors and is within a range of 30% to more than 90%. Clinical attempts to enhance activity of immunochemotherapy in high-risk DLBCL like ABC or others included adding targeted agents to the R-CHOP backbone: bortezomib, lenalidomide, ibrutinib. Unfortunately, randomized clinical trials did not confirm the expected benefit. Recently, advanced molecular techniques were used to classify B-cell lymphomas beyond COO or MYC alterations and correlated with clinical outcome as illustrated by 2 recently published influential studies from the National Institutes of Health and from Dana Farber Cancer Center, USA. Advanced molecular pathogenesis descriptions of DLBCL provide a framework for actionable classifications that should be used for designing future clinical trials and hopefully bring success to treatment of high-risk aggressive lymphoma.<\/jats:p>","DOI":"10.1136\/jim-2019-001169","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T06:15:13Z","timestamp":1572502513000},"page":"331-334","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Aggressive B-Cell Lymphoma: Chasing the Target"],"prefix":"10.1177","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-2674","authenticated-orcid":false,"given":"Jan","family":"Walewski","sequence":"first","affiliation":[{"name":"Lymphoid Malignancy, Maria Sklodowska-Curie Institute - Oncology Center, Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"bibr1-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"bibr2-jim-2019-001169","volume-title":"Nowotwory z\u0142o\u015bliwe w Polsce w 2016 roku. Krajowy Rejestr Nowotwor\u00f3w, Zak\u0142ad Epidemiologii i Prewencji Nowotwor\u00f3w, Centrum Onkologii - Instytut im. Marii Sk\u0142odowskiej-Curie, Narodowy Program Zwalczania Chor\u00f3b","author":"Wojciechowska U","year":"2018"},{"key":"bibr3-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01314"},{"key":"bibr4-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01583"},{"key":"bibr5-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-524108"},{"key":"bibr6-jim-2019-001169","unstructured":"Kahl BS, Landsburg DJ. Exploiting the molecular heterogeneity of aggressive B-cell lymphomas to develop effective new therapies., 2019. Available: https:\/\/dailynews.ascopubs.org\/do\/10.1200\/ADN.19.190191\/full\/?cid=DM2180&bid=16934439"},{"key":"bibr7-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.2784"},{"key":"bibr8-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30935-5"},{"key":"bibr9-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.3402"},{"key":"bibr10-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01994"},{"key":"bibr11-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3884"},{"key":"bibr12-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70311-0"},{"key":"bibr13-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02403"},{"key":"bibr14-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1002\/hon.5_2629"},{"key":"bibr15-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1002\/hon.6_2629"},{"key":"bibr16-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445"},{"key":"bibr17-jim-2019-001169","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0016-8"}],"container-title":["Journal of Investigative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1136\/jim-2019-001169","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1136\/jim-2019-001169","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1136\/jim-2019-001169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:43:07Z","timestamp":1777459387000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1136\/jim-2019-001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/jim-2019-001169"],"URL":"https:\/\/doi.org\/10.1136\/jim-2019-001169","relation":{},"ISSN":["1081-5589","1708-8267"],"issn-type":[{"value":"1081-5589","type":"print"},{"value":"1708-8267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}